However, none of the 2,322 NF1 individuals retrospectively assessed for cardiovascular malformation in the National Neurofibromatosis Foundation International Database had HCM[24], suggesting that routine echocardiography should form part of the surveillance regimen in NF1. The gene discussed is NF1; the disease is neurofibromatosis type 1.